No Detail Found!

Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence.

Author(s)
Ammara Mushtaq Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan
Subika Khatoon Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan
Muhammad Asif Qureshi Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan
Abstract
Idiopathic Pulmonary Haemosiderosis (IPH) is a rare disease commonly affecting the paediatric population with approximately 500 globally reported cases in the literature. The disease usually presentswith a symptom triad consisting of ferropenic anaemia, cough with haemoptysis and diffuse bilateral alveolar infiltrates. Therapeutic options for this disorder are not only limited but also not fully effective. Moreover, corticosteroids remain the mainstay of IPH treatment. This communication reviews the available evidence in support of corticosteriod usage in the treatment of IPH. We conclude that the use of corticosteroid in IPH treatment is unfathomed and demands further investigation.
Publication Details
Page(s) 487-489
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 31, Issue: 2, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

72

Views